Company intelligence / Profile preview

SRI International

Menlo Park, California, United Statessri.com ↗

Ownership: Private
Employees: ~1500
Development stage: Commercial

Overview

SRI International conducts hundreds of R&D projects annually across government and commercial sectors. Recent highlights include FDA clearance for a high-dose naloxone clinical trial targeting opioid overdose fatalities. The organization has contributed to the development of cancer drugs and medical devices such as ultrasound technology. Its impact spans from early-stage discovery through translational research to commercialization.

Therapeutic areas: OncologyPsychiatryNeurologyOther
Modalities: Small moleculeBiologicDeviceMonoclonal antibody
Industry: Academic Hospital/University/Research

Partnerships

Government agencies including NIH/NIDA/FDAcommercial clients in pharma/biotech sectorsacademic collaborations are frequent but not individually listed

Beyond the preview

Go deeper on SRI International.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SRI International.

Explore the full profile